openPR Logo
Press release

Global Peptides and Heparin Market Research by Region - North America, Latin America, Europe, Japan, APEJ, MEA; Product Type - Sodium Heparin, Ammonium Heparin, lithium Heparin, Icatibant, Bivalirudin, Liraglutide, Exenatide, Goserelin, Bortezomib, Other

07-27-2018 12:57 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Fact.MR

/ PR Agency: media@factmr.com
Fact.MR

Fact.MR

A fresh study, covering “Peptide and Heparin Market Research Forecast, Trend Analysis & Competition Tracking – Global Review 2017 to 2026” has been broadcasted to wide online repository of Fact MR, which presents deep focus on the healthcare market. This smart study contains precise data that offers a clear insight about market current scenario and future projections for the benefit of readers. Moreover, the study enclosed significant data which tends to make the research a powerful source for analysts and industry experts who are looking to gain necessary knowledge about the prevailing market trends, opportunities and drivers present in the peptide and heparin market. 

Request Sample Report@ https://www.factmr.com/connectus/sample?flag=S&rep_id=378

Drug Developers Shifting Back to Peptides owing to Mounting Challenges regarding Small Molecules

While the pharmaceutical sector discerned small molecules as the medicinal agents, therapeutic peptides were considered to be niche products. However, with mounting challenges regarding small molecules, drug developers are shifting their concentration back to small amino acid chains. Although peptides have been deemed ineffective for developing drugs, modern peptide drug designs and formulations have been developed for circumventing their weaknesses. For example, original requirement for injecting peptides such as insulin is fading, with more patient-friendly administrations progressively being developed. In addition, the current society that critically judges undesirable effects and environmental impact of the candidate medicines is embracing the safety offered by peptides.

Heparin is being extensively employed as an antitumor and anti-inflammatory agent. The anti-inflammatory characteristic of heparin, which prevents metastatic spreading of tumor cells, is a new research finding among healthcare professionals. The metastatic spreading of tumor cells is restricted by heparin through neutralization of cationic mediators, inhibition of heparanase, and adhesion molecules. Recent discoveries have meant that heparin is capable of targeting L- and P-selectin & integrin activity, as well as preventing cancer progression.

Liraglutide and ammonium heparin are expected to remain fast-expanding products in the market. In addition, sales of exenatide, lithium heparin, and sodium heparin will register a similar CAGR through 2026.

Key Research Findings from Fact.MR’s Report on Peptide and Heparin Market

1- Oral route of administration will remain preferred for peptide and heparin

2- Cancer will continue to be the dominant indication segment in the market, in terms of revenues

3- Hospital pharmacies will remain the most lucrative distribution channel for peptide and heparin

Competition Tracking

The global market for peptide and heparin is high fragmented and competitive owing to the presence of a large number of international and regional vendors. These vendors are continuously focusing on the development of generic formulations related to blood coagulation and several other novel therapeutic areas. Companies having the capability of manufacturing drugs for effective treatment of coagulation disorders, along with high efficacy and safety profiles are likely to gain maximum market shares in the foreseeable future. Key market participants identified by the report include Baxter, Celsus, Biofer S.p.A,, Hemmo Pharma, AmbioPharm, Inc., Wockhardt Ltd., Sun Pharmaceutical Industries Ltd., Bachem, Abbott Laboratories, Pfizer Inc., Aspen, Leo Pharma, Teva, Takeda, Sanofi, Novo Nordisk, and Eli Lilly.

View Full Report with TOC@ https://www.factmr.com/report/378/peptides-heparin-market

Table of Contents:

Global Economic Outlook
Global Peptide and Heparin Market - Executive Summary
Global Peptide and Heparin Market Overview
3.1. Introduction
     3.1.1. Global Peptide and Heparin Market Taxonomy
     3.1.2. Global Peptide and Heparin Market Definition
3.2. Global Peptide and Heparin Market Size (US$ Mn) and Forecast, 2012-2026
       3.2.1. Global Peptide and Heparin Market Y-o-Y Growth
3.3. Global Peptide and Heparin Market Dynamics
3.4. Supply Chain
3.5. Cost Structure
3.6. PESTLE Analysis
3.7. Product Lifecycle
3.8. List of Distributors
3.9. Key Participants Market Presence (Intensity Map) By Region
Global Peptide and Heparin Market Analysis and Forecast 2012-2026 
4.1. Global Peptide and Heparin Market Size and Forecast By Product Type , 2012-2026
     4.1.1. Sodium Heparin Market Size and Forecast, 2012-2026
              4.1.1.1. Revenue (US$ Mn) Comparison, By Region
                4.1.1.2. Market Share Comparison, By Region
                4.1.1.3. Y-o-Y growth Comparison, By Region
Continued………

Buy this Report@ https://www.factmr.com/checkout/378/S

About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Follow Us on Linkedin: https://www.linkedin.com/company/factmr/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Peptides and Heparin Market Research by Region - North America, Latin America, Europe, Japan, APEJ, MEA; Product Type - Sodium Heparin, Ammonium Heparin, lithium Heparin, Icatibant, Bivalirudin, Liraglutide, Exenatide, Goserelin, Bortezomib, Other here

News-ID: 1149975 • Views: 189

More Releases from Fact.MR

11-17-2022 | Health & Medicine
Fact.MR
ENT Devices Market Revenue Will Grow 1.8x By 2032
The examination report distributed by Fact.MR on the ENT Devices Market is expected to offer dependable information on different key variables forming the development bend of the market. This report fills in as a rich wellspring of data for key elements, for example, strategy producers, end-use ventures, financial backers, and assessment pioneers. The section represented an extensive offer in the ENT Devices Market in conjecture period 2022 to 2032. The offer
11-17-2022 | Health & Medicine
Fact.MR
Lateral Flow Assays Market Is Projected To Grow At A CAGR Of 4.7% Over The Comin …
The examination report distributed by Fact.MR on the Lateral Flow Assays Market is expected to offer dependable information on different key variables forming the development bend of the market. This report fills in as a rich wellspring of data for key elements, for example, strategy producers, end-use ventures, financial backers, and assessment pioneers. The section represented an extensive offer in the Lateral Flow Assays Market in conjecture period 2022 to
Automated Storage and Retrieval Systems Market estimates to reach a market value …
The global market for automated storage and retrieval systems (ASRS) is expected to grow from 10.2 billion in 2022 to 24 billion by 2032. During the forecast period of 2022-32, ASRS demand is expected to grow at a rate of more than 9.1% per year, primarily due to its use in retail warehouses. 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.factmr.com/connectus/sample?flag=S&rep_id=1869 These computerized inventory management systems are preferred by various manufacturing
Triethanolamine Market is expected to close at 5% CAGR during Forecast 2021-2031
Fact.MR forecasts a close to 5% CAGR in triethanolamine sales from 2021 to 2031. In terms of volume, demand is expected to rise at a CAGR of around 4% over the same time period. By 2031, the market is expected to be worth approximately US$ 1.7 billion. 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.factmr.com/connectus/sample?flag=S&rep_id=1810 Demand for 99% purity triethanolamine is expected to increase by 144 BPS over the next ten

All 5 Releases


More Releases for Heparin

Global Heparin(Heparin Sodium and Heparin Calcium) Market drivers, restraints, g …
Latest industry research report on: Global Heparin(Heparin Sodium and Heparin Calcium) Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts This report studies the global Heparin(Heparin Sodium and Heparin Calcium) market status and forecast, categorizes the global Heparin(Heparin Sodium and Heparin Calcium) market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China,
Global Heparin(Heparin Sodium and Heparin Calcium) Market Professional Survey Re …
"The Report Global Heparin(Heparin Sodium and Heparin Calcium) Market Professional Survey Report 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" This report studies Heparin(Heparin Sodium and Heparin Calcium) in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report
07-18-2017 | Health & Medicine
Heparin
2014 - 2022: Qualitative And Quantitative Analysis Of Heparin Market In Europe B …
Researchmoz added Most up-to-date research on "2014 - 2022: Qualitative And Quantitative Analysis Of Heparin Market In Europe By Product Such As Unfractionated Heparin, Low Molecular Weight Heparin & Ultra Low Molecular Weight Heparin" to its huge collection of research reports. This report provides in-depth analysis of the heparin market in Europe. Stakeholders for this report include manufacturers of heparin products, crude heparin suppliers, heparin processing companies, and new players planning
Heparin Market: Rapid Growth of Heparin Market Anticipated in Several European N …
Europe is among the major regions contributing to the global heparin market owing to its developed economy and high prevalence of coagulation disorders. According to the Ageing Report published by the European Commission in 2015, the percentage of population aged above 65 years is expected to increase from 21.0% in 2013 to 32.0% in 2060. Aging is directly proportional to the rising incidence of venous thromboembolism (VTE) diseases such as
Heparin Market: Rapid Growth of Heparin Market Anticipated in Several European N …
Europe is among the major regions contributing to the global heparin market owing to its developed economy and high prevalence of coagulation disorders. According to the Ageing Report published by the European Commission in 2015, the percentage of population aged above 65 years is expected to increase from 21.0% in 2013 to 32.0% in 2060. Aging is directly proportional to the rising incidence of venous thromboembolism (VTE) diseases such as
Heparin Market Research (Unfractionated Heparin, Low Molecular Weight Heparin & …
This report provides in-depth analysis of the heparin market in Europe. Stakeholders for this report include manufacturers of heparin products, crude heparin suppliers, heparin processing companies, and new players planning to enter the market. The report provides qualitative and quantitative analysis of the heparin market in Europe. Qualitative analysis comprises market dynamics, trends, product overview, and country-level market information. Quantitative analysis includes market share held by companies in 2013, market size,